Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FzioMed Inc.

www.fziomed.com

Latest From FzioMed Inc.

FzioMed Oxiplex Dispute Panel Postponed So CDRH Can Review More Data

With more data submitted to CDRH, FzioMed and the device center have agreed to postpone a planned June 10 dispute-resolution panel meeting on the firm’s previously rejected PMA for the Oxiplex spine surgery gel.

Medical Device Regulation

Regulatory Roundup: FDA Panels; Proteomics; Experiential Learning; 510(k)s

FDA has officially scheduled the first meeting of its Medical Devices Dispute Resolution Panel in more than seven years to assess the case of FzioMed Inc.’s PMA for the Oxiplex gel for lumbar spine surgery. An ophthalmic devices panel has been set for a new corneal implant, and more regulatory news.

Medical Device Regulation

Regulatory Briefs: IVD Draft Guidance; Dispute Panel; Risk Communication

FDA releases draft guidance on human leukocyte antigen test kits. Wright Medical announces its Augment bone graft will go to FDA’s Dispute Resolution Panel. More news.

Medical Device Regulation

FzioMed Gets Second Chance For Oxiplex Gel PMA With Dispute Resolution Panel

FDA granted FzioMed’s petition for an independent review of its Oxiplex gel PMA by the Medical Devices Dispute Resolution Panel in response to FzioMed’s November 2012 petition. The agency deemed the device, intended for use in spine surgery, as “not approvable” in 2008.

Medical Device Regulation
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
  • Pharmaceuticals
    • Drug Delivery
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • FzioMed Inc.
  • Senior Management
  • Ronald F Haynes, Pres. & CFO
    John M Blackmore, VP, Mktg. & Bus. Dev.
    Ronald J Ehmsen, VP, Clinical Affairs
  • Contact Info
  • FzioMed Inc.
    Phone: (805) 546-0610
    170-A Granada Drive
    San Luis Obispo, CA 93401
    USA
UsernamePublicRestriction

Register